Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00044356
Status:
COMPLETED
Last Update Posted:
2011-07-07
First Post:
2002-08-26
Brief Title:
Phase II Trial of Allovectin-7 for Metastatic Melanoma
Sponsor:
Vical
Organization:
Vical
Organization Data
Organization:
Vical
Class:
INDUSTRY
Study ID:
VCL-1005-208
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Vical
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Dmitri D Kharkevitch MD PhD
Old Organization:
Vical Incorporated